Shandong Weigao Group Medical Polymer 将来の成長

Future 基準チェック /16

Shandong Weigao Group Medical Polymer利益と収益がそれぞれ年間10.1%と7.1%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に9.2% 10%なると予測されています。

主要情報

10.1%

収益成長率

10.0%

EPS成長率

Medical Equipment 収益成長	17.1%
収益成長率	7.1%
将来の株主資本利益率	9.2%
アナリストカバレッジ	Good
最終更新日	21 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

OTCPK:SHWG.F - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	15,585	2,501	2,201	3,576	6
12/31/2025	14,731	2,319	1,962	3,013	7
12/31/2024	13,819	2,135	2,086	2,716	7
6/30/2024	12,967	1,912	2,018	2,704	N/A
3/31/2024	13,098	1,957	2,066	2,751	N/A
12/31/2023	13,229	2,002	2,113	2,799	N/A
9/30/2023	13,398	2,221	1,639	2,539	N/A
6/30/2023	13,566	2,440	1,166	2,280	N/A
3/31/2023	13,657	2,602	1,173	2,287	N/A
12/31/2022	13,747	2,764	1,181	2,295	N/A
9/30/2022	13,903	2,676	1,433	2,573	N/A
6/30/2022	14,058	2,589	1,685	2,852	N/A
3/31/2022	13,633	2,432	1,803	2,969	N/A
12/31/2021	13,209	2,276	1,920	3,087	N/A
9/30/2021	12,923	2,288	2,021	3,088	N/A
6/30/2021	12,636	2,300	2,121	3,089	N/A
3/31/2021	12,129	2,194	1,971	2,938	N/A
12/31/2020	11,622	2,087	1,821	2,788	N/A
9/30/2020	11,139	1,998	1,557	2,533	N/A
6/30/2020	10,656	1,909	1,292	2,277	N/A
3/31/2020	10,520	1,879	1,315	2,300	N/A
12/31/2019	10,384	1,850	1,337	2,322	N/A
9/30/2019	9,993	1,805	1,456	2,347	N/A
6/30/2019	9,602	1,760	1,575	2,371	N/A
3/31/2019	9,205	1,616	1,500	2,295	N/A
12/31/2018	8,809	1,473	1,424	2,219	N/A
6/30/2018	7,465	1,255	383	1,812	N/A
3/31/2018	6,879	1,255	N/A	1,539	N/A
12/31/2017	6,293	1,255	N/A	1,266	N/A
6/30/2017	5,402	1,297	N/A	1,233	N/A
3/31/2017	5,511	1,165	N/A	1,143	N/A
12/31/2016	5,620	1,033	N/A	1,053	N/A
9/30/2016	6,484	1,010	N/A	1,042	N/A
6/30/2016	6,237	914	N/A	1,030	N/A
3/31/2016	6,078	1,013	N/A	1,041	N/A
12/31/2015	5,919	1,113	N/A	1,053	N/A
9/30/2015	5,878	1,237	N/A	N/A	N/A
6/30/2015	5,610	1,196	N/A	622	N/A
3/31/2015	5,548	1,161	N/A	N/A	N/A
12/31/2014	5,278	1,085	N/A	711	N/A
9/30/2014	5,011	307	N/A	N/A	N/A
6/30/2014	4,996	431	N/A	794	N/A
3/31/2014	4,769	376	N/A	N/A	N/A
12/31/2013	4,613	388	N/A	720	N/A

アナリストによる今後の成長予測

収入対貯蓄率: SHWG.Fの予測収益成長率 (年間10.1% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: SHWG.Fの収益 ( 10.1% ) US市場 ( 15.4% ) よりも低い成長が予測されています。

高成長収益: SHWG.Fの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: SHWG.Fの収益 ( 7.1% ) US市場 ( 8.9% ) よりも低い成長が予測されています。

高い収益成長: SHWG.Fの収益 ( 7.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: SHWG.Fの自己資本利益率は、3年後には低くなると予測されています ( 9.2 %)。

Shandong Weigao Group Medical Polymer 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Recent updates

Shandong Weigao Group Medical Polymer Company Limited Approves the Distribution of Interim Dividend for the Six Months Ended 30 June 2024, Payable on 22 November 2024

Shandong Weigao Group Medical Polymer Company Limited Proposes an Interim Dividend for the Six Months Ended 30 June 2024, Payable on Before 22 November 2024

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Shandong Weigao Group Medical Polymer Company Limited Approves Board Appointments

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, May 28, 2024

Shandong Weigao Group Medical Polymer Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023

Shandong Weigao Group Medical Polymer Company Limited Approves Distribution of Interim Dividend for the Six Months Ended 30 June 2023

Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2023 Results on Aug 29, 2023

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2022, Payable on or Before 14 July 2023

Shandong Weigao Group Medical Polymer Company Limited Appoints Li Qiang as an Independent Non-Executive Director

Shandong Weigao Group Medical Polymer Company Limited Announces Resignation of Wang Jinxia as an Independent Non-Executive Director of the Company, A Member of Audit Committee, A Member of Remuneration Committee, A Member of Nomination Committee and A Member of Corporate Governance Committee

Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended June 30, 2022, Payable on November 11, 2022

Shandong Weigao Group Medical Polymer Company Limited (SEHK:1066) agreed to acquire Weihai Weigao Medical Materials Company Limited from Weigao Holding Company Limited for approximately RMB288.0 million.

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Changes

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2022 Results on Aug 22, 2022

Shandong Weigao Group Medical Polymer Company Limited Approves Executive Appointments

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Resignations

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, Jun 06, 2022

Shandong Weigao Group Medical Polymer Company Limited Recommends Final Dividend for the Year Ended December 31, 2021

Shandong Weigao Group Medical Polymer Company Limited to Report Q4, 2021 Results on Mar 29, 2022

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended December 31, 2020 At the Annual General Meeting Held on May 24, 2021

Shandong Weigao Group Medical Polymer Company Limited Approves the Appointment of Tang Zheng Peng as a Non-Executive Director of the Company

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Shandong Weigao Group Medical Polymer Company Limited Announces Director Changes

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2020 Results on Aug 26, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘